Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hypoxia × Atovaquone × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Locally Advanced Non-Small Cell Lung Cancer 1 Leukemia, Myeloid, Acute 1 Hypoxia 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 TH 302 2 gadobutrol 1 fluoromisonidazole 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Radiotherapy 1 Propofol 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Ferrosoferric Oxide 1 Dexmedetomidine 1 Blood Specimen Collection 1 Biopsy 1 Bacterial Load 1 Atovaquone 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02628080 2019-09-04

ATOM

University of Oxford

Phase EARLY_PHASE1 Completed

Hypoxia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡